Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
29.18
+0.76 (2.67%)
At close: Mar 27, 2026
SHA:688076 Market Cap
SHA:688076 has a market cap or net worth of 9.22 billion as of March 27, 2026. Its market cap has decreased by -23.71% in one year.
Market Cap
9.22B
Enterprise Value
10.75B
Revenue
1.94B
Ranking
n/a
PE Ratio
28.06
Stock Price
29.18
Market Cap Chart
Since May 20, 2021, SHA:688076's market cap has decreased from 16.52B to 9.22B, a decrease of -44.18%. That is a compound annual growth rate of -11.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 9.22B | -22.60% |
| Dec 31, 2025 | 11.92B | 4.42% |
| Dec 31, 2024 | 11.41B | 19.08% |
| Dec 29, 2023 | 9.58B | 95.95% |
| Dec 30, 2022 | 4.89B | -44.50% |
| Dec 31, 2021 | 8.81B | -46.67% |
| May 20, 2021 | 16.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurisco Pharmaceutical | 10.84B |
| Jiangxi Fushine Pharmaceutical | 10.28B |
| Liaoning Chengda Biotechnology | 10.03B |
| HitGen | 9.94B |
| Chongqing Genrix Biopharmaceutical | 9.57B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 9.51B |
| Bio-Thera Solutions | 9.23B |
| Sino Biological,Inc. | 8.58B |